Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Injections × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 20 Myelodysplastic Syndromes 8 Leukemia, Myelomonocytic, Chronic 7 Carcinoma, Non-Small-Cell Lung 7 Advanced Solid Tumor 6 Triple Negative Breast Neoplasms 4 Solid Tumor 4 Neoplasms 4 Myeloproliferative Disorders 4 Breast Neoplasms 4 Advanced Solid Tumour 4 Advanced Solid Tumors 4 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Monocytic, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Thrombocythemia, Essential 1

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 Radiotherapy, Intensity-Modulated 1 Pemetrexed 1 Paclitaxel 1 Nimorazole 1 Immunotherapy 1 Gemcitabine 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡